-
Abexinostat (INN,
formerly PCI-24781) is an
experimental drug
candidate for
cancer treatment. It was
developed by
Pharmacyclics and
licensed to Xynomic...
- therapies. In 2017,
Xynomic Pharmaceuticals acquired all
global rights to
Abexinostat, Pharmacyclics'
primary commercial product. In
March 2015, Chicago-based...
-
abecarnil (INN)
Abecma abediterol (INN)
Abegrin Abelcet Abenol Abevmy abexinostat (USAN, INN)
Abilify Abilify Asimtufii Abilify Maintena Abilify Maintena...
-
inhibitors 3,3'-Diindolylmethane β-Hydroxybutyric acid (β-hydroxybutyrate)
Abexinostat Acetoacetic acid (acetoacetate)
Allyl mercaptan Apicidin Belinostat Butyric...
-
hydroxamic acids :
vorinostat (SAHA),
belinostat (PXD101), resminostat,
abexinostat, givinostat, LAQ824, ivaltinostat,
nanatinostat and
panobinostat (LBH589)...
-
inhibitors 3,3'-Diindolylmethane β-Hydroxybutyric acid (β-hydroxybutyrate)
Abexinostat Acetoacetic acid (acetoacetate)
Allyl mercaptan Apicidin Belinostat Butyric...
-
inhibitors 3,3'-Diindolylmethane β-Hydroxybutyric acid (β-hydroxybutyrate)
Abexinostat Acetoacetic acid (acetoacetate)
Allyl mercaptan Apicidin Belinostat Butyric...
-
inhibitors 3,3'-Diindolylmethane β-Hydroxybutyric acid (β-hydroxybutyrate)
Abexinostat Acetoacetic acid (acetoacetate)
Allyl mercaptan Apicidin Belinostat Butyric...
-
inhibitors 3,3'-Diindolylmethane β-Hydroxybutyric acid (β-hydroxybutyrate)
Abexinostat Acetoacetic acid (acetoacetate)
Allyl mercaptan Apicidin Belinostat Butyric...
-
inhibitors 3,3'-Diindolylmethane β-Hydroxybutyric acid (β-hydroxybutyrate)
Abexinostat Acetoacetic acid (acetoacetate)
Allyl mercaptan Apicidin Belinostat Butyric...
